type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 11 of 11

TRENDING

EDITORS CHOICE

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Medika Life -
Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

Amoxicillin

Medika Life -
Amoxicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria

FDA Approves New Opioid, Olinvyk, for Intravenous Use in Hospitals

Medika Life -
the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults

Evrysdi™ Approved for Spinal Muscular Atrophy Home Treatment

Medika Life -
The FDA has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy in children and adults

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories